190 related articles for article (PubMed ID: 31225721)
1. Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
Wang HB; Duan MX; Xu M; Huang SH; Yang J; Yang J; Liu LB; Huang R; Wan CX; Ma ZG; Wu QQ; Tang QZ
J Cell Mol Med; 2019 Aug; 23(8):5715-5727. PubMed ID: 31225721
[TBL] [Abstract][Full Text] [Related]
2. Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway.
Ma ZG; Dai J; Wei WY; Zhang WB; Xu SC; Liao HH; Yang Z; Tang QZ
Int J Biol Sci; 2016; 12(7):861-71. PubMed ID: 27313499
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
Liu ZH; Liu HB; Wang J
Biomed Pharmacother; 2018 Jan; 97():1468-1478. PubMed ID: 29793309
[TBL] [Abstract][Full Text] [Related]
4. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
[TBL] [Abstract][Full Text] [Related]
5. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
Li F; Zhang N; Wu Q; Yuan Y; Yang Z; Zhou M; Zhu J; Tang Q
Int J Mol Med; 2017 Jan; 39(1):199-207. PubMed ID: 27959392
[TBL] [Abstract][Full Text] [Related]
6. 3,3'-Diindolylmethane protects against cardiac hypertrophy via 5'-adenosine monophosphate-activated protein kinase-α2.
Zong J; Deng W; Zhou H; Bian ZY; Dai J; Yuan Y; Zhang JY; Zhang R; Zhang Y; Wu QQ; Guo HP; Li HL; Tang QZ
PLoS One; 2013; 8(1):e53427. PubMed ID: 23326427
[TBL] [Abstract][Full Text] [Related]
7. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
[TBL] [Abstract][Full Text] [Related]
9. Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling.
Zong J; Zhang DP; Zhou H; Bian ZY; Deng W; Dai J; Yuan Y; Gan HW; Guo HP; Tang QZ
J Cell Biochem; 2013 May; 114(5):1058-65. PubMed ID: 23225340
[TBL] [Abstract][Full Text] [Related]
10. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
11. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
[TBL] [Abstract][Full Text] [Related]
12. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
13. Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
Xu M; Wan CX; Huang SH; Wang HB; Fan D; Wu HM; Wu QQ; Ma ZG; Deng W; Tang QZ
Cell Death Dis; 2019 May; 10(6):403. PubMed ID: 31127082
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling.
Zhang X; Ma ZG; Yuan YP; Xu SC; Wei WY; Song P; Kong CY; Deng W; Tang QZ
Cell Death Dis; 2018 Jan; 9(2):102. PubMed ID: 29367637
[TBL] [Abstract][Full Text] [Related]
15. Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.
Gao L; Yao R; Liu Y; Wang Z; Huang Z; Du B; Zhang D; Wu L; Xiao L; Zhang Y
Mol Cell Biochem; 2017 May; 429(1-2):167-177. PubMed ID: 28176246
[TBL] [Abstract][Full Text] [Related]
16. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
[TBL] [Abstract][Full Text] [Related]
17. Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
Deng W; Jiang D; Fang Y; Zhou H; Cheng Z; Lin Y; Zhang R; Zhang J; Pu P; Liu Y; Bian Z; Tang Q
J Mol Histol; 2013 Oct; 44(5):575-85. PubMed ID: 23719775
[TBL] [Abstract][Full Text] [Related]
18. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
[TBL] [Abstract][Full Text] [Related]
19. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
J Cell Mol Med; 2016 Jan; 20(1):48-57. PubMed ID: 26515045
[TBL] [Abstract][Full Text] [Related]
20. Icariside II attenuates cardiac remodeling via AMPKα2/mTORC1 in vivo and in vitro.
Liu XY; Liao HH; Feng H; Zhang N; Yang JJ; Li WJ; Chen S; Deng W; Tang QZ
J Pharmacol Sci; 2018 Sep; 138(1):38-45. PubMed ID: 30241784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
